Research ArticleCORONAVIRUS

IgA dominates the early neutralizing antibody response to SARS-CoV-2

See allHide authors and affiliations

Science Translational Medicine  20 Jan 2021:
Vol. 13, Issue 577, eabd2223
DOI: 10.1126/scitranslmed.abd2223
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article